Literature DB >> 23990295

Phenotypic and genotypic analysis of clarithromycin-resistant Helicobacter pylori from Bogotá D.C., Colombia.

Alba A Trespalacios1, William Otero, Jorge E Caminos, Marcela M Mercado, Jenny Avila, Liliana E Rosero, Azucena Arévalo, Raúl A Poutou-Piñales, David Y Graham.   

Abstract

Resistance of Helicobacter pylori to clarithromycin is the most common cause of treatment failure in patients with H. pylori infections. This study describes the MICs and the presence of 23S rRNA mutations of H. pylori isolates from Bogotá, D.C., Colombia. H. pylori were isolated from gastric biopsies from patients with functional dyspepsia. Clarithromycin susceptibility was investigated by agar dilution and strains were considered resistant if the MIC was ≥ 1 μg/ml. DNA sequences of the 23S rRNA gene of strains resistant and sensitive to clarithromycin were determined to identify specific point mutations. Clarithromycin resistance was present in 13.6% of patients by agar dilution. The A2143G, A2142G and A2142C mutations were found in 90.5, 7.1, and 2.4% of H. pylori strains with resistance genotype.The resistant phenotype was associated with 23S rRNA resistance genotype in 85.7% of isolates. The point mutations in 23S rRNA were well correlated with MICs values for clarithromycin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990295     DOI: 10.1007/s12275-013-2465-6

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  34 in total

1.  Prevalence of cagA, vacA, babA2 and iceA genes in H. pylori strains isolated from Colombian patients with functional dyspepsia.

Authors:  Azucena Arévalo-Galvis; Alba A Trespalacios-Rangell; William Otero; Marcela M Mercado-Reyes; Raúl A Poutou-Piñales
Journal:  Pol J Microbiol       Date:  2012

2.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

3.  Antibiotic resistance of Helicobacter pylori strains in Japanese children.

Authors:  Seiichi Kato; Shigeru Fujimura; Hirokazu Udagawa; Toshiaki Shimizu; Shunichi Maisawa; Kyoko Ozawa; Kazuie Iinuma
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance.

Authors:  J Versalovic; M S Osato; K Spakovsky; M P Dore; R Reddy; G G Stone; D Shortridge; R K Flamm; S K Tanaka; D Y Graham
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

5.  Detection of clarithromycin-resistant helicobacter pylori strains by a preferential homoduplex formation assay.

Authors:  S Maeda; H Yoshida; H Matsunaga; K Ogura; O Kawamata; Y Shiratori; M Omata
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.

Authors:  Kenro Hirata; Hidekazu Suzuki; Toshihiro Nishizawa; Hitoshi Tsugawa; Hiroe Muraoka; Yoshimasa Saito; Juntaro Matsuzaki; Toshifumi Hibi
Journal:  J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 4.029

7.  Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens.

Authors:  A Marais; L Monteiro; A Occhialini; M Pina; H Lamouliatte; F Mégraud
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

8.  Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations.

Authors:  D E Taylor; Z Ge; D Purych; T Lo; K Hiratsuka
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

9.  Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond.

Authors:  David Y Graham; Hong Lu; Yoshio Yamaoka
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Evaluation of techniques for isolation, subcultivation, and preservation of Helicobacter pylori.

Authors:  R Ansorg; G Von Recklinghausen; R Pomarius; E N Schmid
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  2 in total

Review 1.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Surveillance of Levofloxacin Resistance in Helicobacter pylori Isolates in Bogotá-Colombia (2009-2014).

Authors:  Alba A Trespalacios-Rangél; William Otero; Azucena Arévalo-Galvis; Raúl A Poutou-Piñales; Emiko Rimbara; David Y Graham
Journal:  PLoS One       Date:  2016-07-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.